Non-specific immunity-enhancing effects of tryptic casein hydrolysate versus Fermosorb for treatment/prophylaxis of newborn calf colibacillosis

FEMS Immunology and Medical Microbiology

Volumn 39, Issue 2, 2003, Pages 155-161

  Biziulevičius, Gediminas A ^a   Žukaite, Vilhelmina ^a   Normantiene, Teresa ^a   Biziulevičiene, Gene ^a   Arestov, Ivan G ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b Vitebsk State Academy of Veterinary Medicine   (Belarus)

Author keywords

Antimicrobial activity; Enzymotherapy; Immunostimulatory activity; Newborn calf colibacillosis; Tryptic casein hydrolysate

Indexed keywords

ANTIINFECTIVE AGENT; CASEIN HYDROLYSATE; FERMOSORB; HEMOGLOBIN; IMMUNOGLOBULIN; IMMUNOSTIMULATING AGENT; PROTEIN; THIOL GROUP; UNCLASSIFIED DRUG; VETERINARY DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CATTLE DISEASE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG POTENTIATION; ENTEROBACTER INFECTION; ENZYME THERAPY; HEMATOCRIT; HEMOGLOBIN DETERMINATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; INFECTION PREVENTION; NEWBORN CALF COLIBACILLOSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 18244427231     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00222-0     Document Type: Article

References (50)

1. Smith R.D., Coast J. Antimicrobial resistance: a global response. Bull. WHO. 80:2002;126-133.
2. Schwarz S., Chaslus-Dancla E. Use of antibiotics in veterinary medicine and mechanisms of resistance. Vet. Res. 32:2001;201-225.
3. Lohner, K. (Ed.) (2001) Development of Novel Antimicrobial Agents: Emerging Strategies. Horizon Scientific Press, Wymondham.
4. Poole K. Overcoming antimicrobial resistance by targeting resistance mechanisms. J. Pharm. Pharmacol. 53:2001;283-294.
5. Ibrahim H.R., Aoki T., Pellegrini A. Strategies for new antimicrobial proteins and peptides: lysozyme and aprotinin as model molecules. Curr. Pharm. Design. 8:2002;671-693.
6. Scott M.G., Hancock R.E.W. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 20:2000;407-431.
7. Labro M.T. Interference of antibacterial agents with phagocyte functions: immunomodulation or 'immuno-fairy tales'? Clin. Microbiol. Rev. 13:2000;615-650.
8. Sava, G. (1996) Pharmacological aspects and therapeutic applications of lysozymes. In: Lysozymes: Model Enzymes in Biochemistry and Biology (Jollès, P., Ed.), pp. 433-449. Birkhäuser Verlag, Basel.
9. Kislukhina, O.V. (2002) Enzymes in Production of Food and Forage, pp. 311-313. DeLi, Moscow.
10. Kislukhina, O.V., Kalunyants, K.A. and Alenova, D.Zh. (1990) Enzymatic Lysis of Microorganisms. Rauan, Alma-Ata.
11. Kariyama, R. and Shockman, G. (1992) Autolysins. In: Bacterial Growth and Lysis: Metabolism and Structure of the Bacterial Sacculus (de Pedro, M., Höltje, J. and Loffelhardt, W., Eds.), pp. 229-234. Plenum Press, New York.
12. Shockman, G.D. and Höltje, J.-V. (1994) Microbial peptidoglycan (murein) hydrolases. In: Bacterial Cell Wall (Ghuysen, J.-M. and Hakenbeck, R., Eds.), pp. 131-166. Elsevier, Amsterdam.
13. Biziulevichius G.A.S., Kislukhina O.V. Lytic enzymes in veterinary medicine. A review. Veterinariya (Moscow). 3:1988;56-59.
14. Biziulevichius G.A.S., Shablinskas A.J., Zhukaite V.P., Kislukhina O.V. Antibacterial spectrum of lysosubtilin G 10× Antibiot. Khimioter. (Moscow). 34:1989;579-581.
15. Biziulevichius G.A., Zhukaite W., Kislukhina O. Lysosubtilin - a broad-spectrum action preparation of lytic enzymes for veterinary use: in vitro studies on activators and inhibitors, complex structure and antifungal action. Biomed. Lett. 52:1995;43-57.
16. Biziulevichius G.A., Lukauskas K. In vivo studies on lysosubtilin. 2. Efficacy for treatment of post-partum endometritis in cows. Vet. Res. 29:1998;47-58.
17. Biziulevichius G.A., Lukauskas K. In vivo studies on lysosubtilin. 3. Efficacy for treatment of mastitis and superficial lesions of the udder and teats in cows. Vet. Res. 29:1998;441-456.
18. Biziulevichius G.A., Arestov I.G. In vivo studies on lysosubtilin. 1. Efficacy for prophylaxis and treatment of gastrointestinal disorders in newborn calves. Vet. Res. 28:1997;19-35.
19. Biziulevičius G.A., Žukaitė V. Lysosubtilin modification, Fermosorb, designed for polymeric carrier-mediated intestinal delivery of lytic enzymes: pilot-scale preparation and evaluation of this veterinary medicinal product. Int. J. Pharmacol. 189:1999;43-55.
20. Biziulevičius G.A., Žukaitė V. Comparative antimicrobial activity of lysosubtilin and its acid-resistant derivative, Fermosorb. Int. J. Antimicrob. Agents. 20:2002;65-68.
21. Goldman R.C., Branstrom A. Targeting cell wall synthesis and assembly in microbes: Similarities and contrasts between bacteria and fungi. Curr. Pharm. Design. 5:1999;473-501.
22. Koch A.L. The exoskeleton of bacterial cells (the sacculus): still a highly attractive target for antibacterial agents that will last for a long time. Crit. Rev. Microbiol. 26:2000;1-35.
23. Kislukhina, O.V., Kuznetsova, T.A., Kalunyants, K.A. and Bandoyan, A.K. (1981) Method for preparation of an activator of microbial autolysis. USSR Invention 969 715.
24. Biziulevičius G.A., Kislukhina O.V., Žukaitė V., Normantienė T., Arestov I.G. Stimulation of microbial autolytic system by tryptic casein hydrolysate. Int. J. Antimicrob. Agents. 20:2002;361-365.
25. Fraser, C.M., Bergeron, J.A., Mays, A. and Aiello, S.E. (Eds.) (1991) The Merck Veterinary Manual. A Handbook of Diagnosis, Therapy, and Disease Prevention and Control for the Veterinarian, 7th edn., pp. 181-184. Merck and Co., Inc., Rahway, NJ.
26. Smirnov, A.M., Konopeljko, P.Ya., Postnikov, V.S., Belyakov, I.M., Dugin, G.L., Pushkarev, R.P., Kondratjev, V.S. and Urazaev, N.A. (1981) Clinical Diagnostics of Internal Noninfectious Diseases in Livestock. Kolos, Leningrad.
27. Matusevich V.F., Bityukov V.A., Vysokos N.P., Dmitriev A.F., Nagornaya T.S. Ways of determining natural resistance of livestock. Trud. Tselinogradsk. Skh. Inst. 8:1971;8-19.
28. Dorofeichuk V.G. Determination of lysozyme activity nephelometrically. Lab. Delo. 1:1968;28-30.
29. Kedrova, E.M. (1962) Determination of sulfhydryl groups by way of amperometric titration (Methodological letter). Institute of Biological and Medical Chemistry of the USSR Academy of Medical Sciences, Moscow.
30. Kislukhina O.V. Determination of lytic activity of lysosubtilin by action towards Escherichia coli cells. Mikrobiol. Promyshl. 141:1976;43-45.
31. Meisel H. Biochemical properties of bioactive peptides derived from milk proteins: potential nutraceuticals for food and pharmacological applications. Livestock Prod. Sci. 50:1997;125-138.
32. Meisel H. Overview on milk protein-derived peptides. Int. Dairy J. 8:1998;363-373.
33. Meisel H., Bockelmann W. Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie van Leeuwenhoek. 76:1999;207-215.
34. Werner G.H., Jollès P. Immunostimulating agents: what next? A review of their present and potential medical applications. Eur. J. Biochem. 242:1996;1-19.
35. Fiat A.M., Jollès P. Caseins of various origins and biologically active casein peptides and oligosaccharides: Structural and physiological aspects. Mol. Cell. Biochem. 87:1989;5-30.
36. Otani H. Enhancement of IgA levels by casein phosphopeptides. Curr. Res. Adv. Agric. Biol. Chem. 1:2001;11-21.
37. Otani H., Hata I. Inhibition of proliferative responses of mouse spleen lymphocytes and rabbit Peyer's patch cells by bovine milk casein and their digests. J. Dairy Res. 62:1995;339-348.
38. Lahov E., Regelson W. Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food Chem. Toxicol. 34:1996;131-145.
39. Liepke C., Zucht H.D., Forssmann W.G., Standker L. Purification of novel peptide antibiotics from human milk. J. Chromatogr. B Biomed. Sci. Appl. 752:2001;369-377.
40. Matin M.A., Otani H. Antimicrobial and cytotoxic peptides released from milk proteins by the action of mammalian gastrointestinal proteinases. Curr. Res. Adv. Agric. Biol. Chem. 1:2001;23-36.
41. Matin M.A., Otani H. Cytotoxic and antibacterial activities of chemically synthesized κ-casecidin and its partial peptide fragments. J. Dairy Res. 69:2002;329-334.
42. Bocci V. The neglected organ: bacterial flora has a crucial immunomodulatory role. Perspect. Biol. Med. 35:1992;251-260.
43. Barot-Ciorbaru R. Immunomodulation by bacterial fractions. Int. J. Immunopharmacol. 16:1994;469-473.
44. Alexander C., Rietschel E.T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7:2001;167-202.
45. Jollès P. A possible physiological function of lysozyme. Biomedicine. 25:1976;275-276.
46. Namba Y., Hidaka Y., Taki K., Morimoto T. Effect of oral administration of lysozyme or digested bacterial cell walls on immunostimulation in guinea pigs. Infect. Immun. 31:1981;580-583.
47. Namioka S., Kumeda Y., Kawamoto T., Wang C.T., Namba Y., Murakami K. The influence of immunopotentiators on suckling piglets with special reference to the incidence of pig scour. Br. Vet. J. 138:1982;155-167.
48. Sasaki T., Maede Y., Namioka S. Immunopotentiation of the mucosa of the small intestine of weaning piglets by peptidoglycan. Jpn. J. Vet. Sci. 49:1987;235-243.
49. Sasaki T., Samegai Y., Namioka S. Phagocytosis of splenetic neutrophils of mice enhanced by orally administered peptidoglycan from Bifidobacterium thermophilum. J. Vet. Med. Sci. 58:1996;85-86.
50. Sakai T., Hamakawa M., Shirai K., Onishi N., Yamashira A., Toride Y. Protective effects of digested bacterial cell powder on diarrhea in suckling piglets. Agri-Practice. 17:1996;23-27.